Literature DB >> 16569549

Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study.

Ingeborg A Brouwer1, Jan Heeringa, Johanna M Geleijnse, Peter L Zock, Jacqueline C M Witteman.   

Abstract

BACKGROUND: Atrial fibrillation is the most common sustained cardiac arrhythmia. It is a major cause of morbidity and mortality through an increased risk of thromboembolic stroke. Experimental as well as observational evidence suggests that n-3 polyunsaturated fatty acids may have antiarrhythmic effects. The objective of this study was to examine whether high intakes of fish and its very long-chain n-3 fatty acids eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) are associated with risk of incident atrial fibrillation.
METHODS: We used data from the Rotterdam Study, a prospective cohort study. At baseline, dietary intake data were available for 5184 subjects free from atrial fibrillation. Dietary intake was assessed using a semiquantitative food-frequency questionnaire, and incidence of atrial fibrillation was continuously monitored during follow-up. Cox proportional hazards model (adjusted for lifestyle and disease factors) was used to examine the associations between intakes of EPA plus DHA and of fish with atrial fibrillation.
RESULTS: After a mean follow-up of 6.4 (+/-1.6) years, 312 subjects developed atrial fibrillation. Intake of EPA and DHA in the third textile compared with first was not associated with risk of atrial fibrillation (relative risk 1.18, 95% CI 0.88-1.57). Furthermore, no association was observed with intake of >20 g/d fish compared with no fish intake (relative risk 1.17, 95% CI 0.87-1.57).
CONCLUSIONS: In this study, intakes of EPA and DHA and the consumption of fish were not associated with the onset of atrial fibrillation. This finding does not support that n-3 fatty acids have a general antiarrhythmic effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16569549     DOI: 10.1016/j.ahj.2005.07.029

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  50 in total

Review 1.  Diet and risk of atrial fibrillation – epidemiologic and clinical evidence –.

Authors:  Noelle N Gronroos; Alvaro Alonso
Journal:  Circ J       Date:  2010-09-11       Impact factor: 2.993

2.  Eicosapentaenoic acid for the prevention of recurrent atrial fibrillation.

Authors:  Eiichi Watanabe; Yoshihiro Sobue; Kan Sano; Kentarou Okuda; Mayumi Yamamoto; Yukio Ozaki
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-10       Impact factor: 1.468

3.  Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.

Authors:  Jason H Y Wu; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Frank M Sacks; Eric B Rimm; Susan R Heckbert; David S Siscovick; Dariush Mozaffarian
Journal:  Circulation       Date:  2012-01-26       Impact factor: 29.690

4.  Omega-3 polyunsaturated fatty acids (PUFAs or fish oils) and atrial fibrillation.

Authors:  T Opthof; H M Den Ruijter
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 5.  Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.

Authors:  Baukje de Roos; Yiannis Mavrommatis; Ingeborg A Brouwer
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

6.  n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling.

Authors:  D N Q da Cunha; R L Hamlin; G E Billman; C A Carnes
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 7.  Fish oils, coronary heart disease, and the environment.

Authors:  Jonathan Greene; Sarah M Ashburn; Louai Razzouk; Donald A Smith
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

8.  Omega-3 fatty acid supplementation for the prevention of arrhythmias.

Authors:  Mina K Chung
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

9.  Recent advances in pharmacotherapy of atrial fibrillation.

Authors:  J Singh; J S Braich
Journal:  Indian J Pharmacol       Date:  2009-08       Impact factor: 1.200

Review 10.  Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance.

Authors:  Irene Savelieva; Antonios Kourliouros; John Camm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-25       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.